Business
HEALWELL AI Announces Strategic Divestments and Progression to a Pure-Play SaaS, Services and AI Business
HEALWELL has divested its Polyclinic Family Medicine and Specialty Group of Clinics to WELL Healt...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL AI Announces Strategic Divestments and Progression to a Pure-Play SaaS, Services and AI BusinessHEALWELL has divested its Polyclinic Family Medicine and Specialty Group of Clinics to WELL Health Clinic Network Inc. (\"WELL Clinics\"), who has been previously managing these clinics for HEALWELL since January 2024.HEALWELL has sold its interest in Mutuo Health Solutions Inc. (\"Mutuo\") to WELLSTAR Technologies Corp. (\"WELLSTAR\"), so it can better focus on its large enterprise healthcare software and AI business. Mutuo is primarily focused on selling solutions to doctors and clinics which aligns better with WELLSTAR's focus and leverages Mutuo as part of its Nexus AI platform.HEALWELL has formed a 50/50 clinical research joint venture with WELL Health Technologies Corp. The joint venture includes Bio Pharma Services Inc. and Canadian Phase Onward Inc. which will no longer be consolidated under HEALWELL. The joint venture will continue the strategic evaluation process to best support the growth opportunity in clinical research.Due to the non-arm's length nature of these transactions, HEALWELL formed a special committee of three directors to assess and approve these transactions, who relied on a fairness opinion from Doane Grant Thornton LLP.Together these transactions allow HEALWELL to become a pure-play digital SaaS, services and AI business, primarily focused on health systems and large enterprises globally with a revenue run rate of approximately $120 million annually and is profitable on an Adjusted EBITDA basis. Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, today announced that it has completed a series of strategic transactions (the \"Transactions\") with WELL Health Technologies Corp. (\"WELL\") and its subsidiaries, WELL Health Clinic Network Inc. (\"WELL Clinics\") and WELLSTAR Technologies Corp. (\"WELLSTAR\"), to streamline operations, accelerate clinical research, and focus on high-growth AI and software initiatives. The transactions include the sale of HEALWELL's Polyclinic Family Medicine and Specialty Clinics Group (\"Polyclinic\") to WELL Clinics, the sale of HEALWELL's interest in Mutuo Health Solutions Inc. (\"Mutuo\") to WELLSTAR, ...